Platelet-Rich stroma from Crohn’s disease patients for treatment of perianal fistula shows a higher myeloid cell profile compared to non-IBD controls

Platelet-Rich stroma from Crohn’s disease patients for treatment of perianal fistula shows a higher myeloid cell profile compared to non-IBD controls

Background: New cell-based therapies are under investigation to improve perianal fistulizing Crohn’s disease (pCD) healing. Autologous stromal vascular fraction combined with platelet-rich plasma (referred to as platelet-rich stroma [PRS]) is a new adipose-derived stromal therapy. The effect of Croh...

Full description

Bibliographic Details
Main Authors: J.H.C. Arkenbosch, M.A.J. Becker, C.J. Buskens, C. Witjes, A.C. de Vries, C.J. van der Woude, G. Fuhler, M.E. Wildenberg, O. van Ruler
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Stem Cell Research
Subjects:
Perianal fistula
Crohn’s disease
Autologous stromal cell therapy
Basic science
Surgery
Online Access:http://www.sciencedirect.com/science/article/pii/S1873506123000259

Internet

http://www.sciencedirect.com/science/article/pii/S1873506123000259

Similar Items